Page last updated: 2024-10-24

carmustine and Gastrointestinal Stromal Tumors

carmustine has been researched along with Gastrointestinal Stromal Tumors in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Gastrointestinal Stromal Tumors: All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ryan, CW1
Dolan, ME1
Brockstein, BB1
McLendon, R1
Delaney, SM1
Samuels, BL1
Agamah, ES1
Vokes, EE1

Trials

1 trial available for carmustine and Gastrointestinal Stromal Tumors

ArticleYear
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
    Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:5

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Enzyme Inhibitors;

2006